LFMD Q2 2024 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$182M

Q2 2024 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$51M+40.9% YoY

Gross Profit

$46M90.1% margin

Operating Income

-$6M-12.4% margin

Net Income

-$7M-13.6% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

+14.8%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$1M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$64M

Total Liabilities

$66M

Stockholders' Equity

-$4M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$51M	$36M	+40.9%
Gross Profit	$46M	$31M	+45.3%
Operating Income	-$6M	-$5M	-28.8%
Net Income	-$7M	-$7M	-2.1%